Giulio Superti-Furga, Ph.D., was born in Milan, Italy, performed his graduate studies at the University of Zurich, Genentech, Inc. and the Institute for Molecular Pathology in Vienna. He completed his Ph.D.at the University of Zurich in 1990. He was a post-doctoral fellow at the EMBL and became a staff scientist in 1993.

In 1995, Dr. Superti-Furga became an independent Team Leader at the EMBL and his research was focussed on tyrosine kinases and signal transduction. He is the author of more than 50 scientific publications and he is credited with discovering the importance of intramolecular interactions in the regulation of oncogenic tyrosine kinases.

He has consulted for major pharmaceutical companies and national and international granting agencies. He also has served as an adjunct professor at the University of Bologna in Italy, the oldest university in the western world.  He is a co-editor for FEBS Letters. Together with other EMBL scientists and international biotechnology industry leaders he has founded the company Cellzome, where he currently serves as Senior Vice President of Biology and Head of the Heidelberg site.